Pharmaceutical Drying Equipment Market by Type (Freeze, Spray, Vacuum, Fluidized Bed), Scale of Operation (Industrial-scale, Pilot-scale, Lab-scale), End User (Pharmaceutical Companies, CDMOs, Research Universities) - Global Forecast to 2029
The global Pharmaceutical Drying Equipment market is projected to reach USD 8.18 billion by 2029 from USD 5.80 billion in 2024, at a CAGR of 7.1% during the forecast period. This is due to growing prevalence of chronic diseases such as diabetes, cardiovascular diseases, cancer, is leading to increase in demand for the pharmaceutical drugs. To meet this increased demand for the medicines the pharmaceutical manufacturing facilities are expanding, consequently increasing the demand for the pharmaceutical equipment dryers. However, the increased demand for the refurbished dryers in pharmaceutical industry is major restraint to the market. Additionally, Higher maintenance of the pharmaceutical drying equipment is major challenge for the market growth. But, the increasing competition in pharmaceutical manufacturing industry due to loss of various drugs' market exclusivity and high growth potential of emerging markets is expected to present profitable growth opportunities for pharmaceutical drying equipment market players over the forecast period of 2024-2029.
“The spray dryer segment of pharmaceutical drying market to hold largest position forecast period.”
Based on the type, the spray dryer segment is anticipated to hold largest share position during forecast period in pharmaceutical drying equipment market. This is due to its versatility, efficiency, and ability to enhance product quality. It offers improved bioavailability by producing dust-free, free-flowing, and easily re-dispersible powders, making it ideal for thermoplastic, hygroscopic, and heat-sensitive products. Spray dryers are essential for maintaining quality of active pharmaceutical ingredient. As spray dryers can handle a wide variety of product types, including granulated and agglomerated forms, without heat deterioration. Its popularity in the sector is also a result of its small size, which guarantees energy-efficient operations and makes it an affordable option for large-scale pharmaceutical production.
“The pilot-scale equipment segment is the fastest growing segment in pharmaceutical drying equipment market.”
Based on scale of operation, the pharmaceutical drying equipment market is segmented into industrial-scale equipment, pilot-scale equipment, and laboratory-scale equipment. The pilot-scale equipment segment is expected to grow at the highest CAGR due to its pivotal role in pharmaceutical research and development (R&D). With increasing development of new medications, pilot-scale equipment allows manufacturers to test formulations and processes on a smaller, more cost-effective scale before full-scale industrial production. This affordability makes it an ideal choice during R&D, minimizing financial risk while optimizing production methods. Additionally, the growing trend of outsourcing manufacturing to Contract Development and Manufacturing Organizations (CDMOs) has further driven the demand for pilot-scale equipment. CDMOs use these systems to streamline the transition from R&D to large-scale production, ensuring efficient and scalable solutions for pharmaceutical companies. As more companies rely on CDMOs to bring new drugs to market, the need for pilot-scale equipment continues to rise, contributing to its rapid growth.
“Europe accounted for the second largest share of the pharmaceutical drying equipment market by region.”
The global pharmaceutical drying equipment market is segmented into five major regions, namely, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Europe is the second largest regional market for pharmaceutical drying equipment, whereas the Asia Pacific market is estimated to grow at the highest CAGR during the forecast period.
Europe holds the second-largest position in the pharmaceutical drying equipment market. This is due to the presence of key industry players such as GEA Group (Germany), I.M.A. Industria Macchine Automatiche (Italy), Syntegon Technology GmbH (Germany), and Mechatech Systems Ltd (UK). These major European players are making significant investments in R&D to create cutting-edge, innovative equipment. Furthermore, the European region's strong pharmaceutical manufacturing base, established regulatory framework, and focus on technological advancements all contribute to its strong market position. In Europe, the need for pharmaceutical drying equipment is being driven by innovation and industry leadership.
A breakdown of the primary participants referred to for this report is provided below:
Note 2: C-level primaries include CEOs, CFOs, COOs, and VPs.
Note 3: Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.
The major players operating in the pharmaceutical drying equipment market market are GEA Group (Germany), ATS Corporation (US), Hosokawa Micron Group (Japan), Freund Corporation (Japan), I.M.A. Industria Macchine Automatiche S.p.A. (Italy), Syntegon Technology GmbH (Germany), BUCHI Labortechnik AG (Switzerland), OPTIMA packaging group GmbH (Germany), Mechatech Systems Ltd (Netherland), and BEW Engineering Limited (India).
Research Coverage
This report studies the pharmaceutical drying equipment market based on type, scale of operation,, end user and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five major regions (and the respective countries in these regions).
Reasons to Buy the Report
The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies for strengthening their market presence.
This report provides insights on the following pointers:
“The spray dryer segment of pharmaceutical drying market to hold largest position forecast period.”
Based on the type, the spray dryer segment is anticipated to hold largest share position during forecast period in pharmaceutical drying equipment market. This is due to its versatility, efficiency, and ability to enhance product quality. It offers improved bioavailability by producing dust-free, free-flowing, and easily re-dispersible powders, making it ideal for thermoplastic, hygroscopic, and heat-sensitive products. Spray dryers are essential for maintaining quality of active pharmaceutical ingredient. As spray dryers can handle a wide variety of product types, including granulated and agglomerated forms, without heat deterioration. Its popularity in the sector is also a result of its small size, which guarantees energy-efficient operations and makes it an affordable option for large-scale pharmaceutical production.
“The pilot-scale equipment segment is the fastest growing segment in pharmaceutical drying equipment market.”
Based on scale of operation, the pharmaceutical drying equipment market is segmented into industrial-scale equipment, pilot-scale equipment, and laboratory-scale equipment. The pilot-scale equipment segment is expected to grow at the highest CAGR due to its pivotal role in pharmaceutical research and development (R&D). With increasing development of new medications, pilot-scale equipment allows manufacturers to test formulations and processes on a smaller, more cost-effective scale before full-scale industrial production. This affordability makes it an ideal choice during R&D, minimizing financial risk while optimizing production methods. Additionally, the growing trend of outsourcing manufacturing to Contract Development and Manufacturing Organizations (CDMOs) has further driven the demand for pilot-scale equipment. CDMOs use these systems to streamline the transition from R&D to large-scale production, ensuring efficient and scalable solutions for pharmaceutical companies. As more companies rely on CDMOs to bring new drugs to market, the need for pilot-scale equipment continues to rise, contributing to its rapid growth.
“Europe accounted for the second largest share of the pharmaceutical drying equipment market by region.”
The global pharmaceutical drying equipment market is segmented into five major regions, namely, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Europe is the second largest regional market for pharmaceutical drying equipment, whereas the Asia Pacific market is estimated to grow at the highest CAGR during the forecast period.
Europe holds the second-largest position in the pharmaceutical drying equipment market. This is due to the presence of key industry players such as GEA Group (Germany), I.M.A. Industria Macchine Automatiche (Italy), Syntegon Technology GmbH (Germany), and Mechatech Systems Ltd (UK). These major European players are making significant investments in R&D to create cutting-edge, innovative equipment. Furthermore, the European region's strong pharmaceutical manufacturing base, established regulatory framework, and focus on technological advancements all contribute to its strong market position. In Europe, the need for pharmaceutical drying equipment is being driven by innovation and industry leadership.
A breakdown of the primary participants referred to for this report is provided below:
- By Company Type: Tier 1–40%, Tier 2–30%, and Tier 3– 30%
- By Designation: C-level–50%, Director-level–30% and Others–20%
- By Region: North America–38%, Europe–26%, Asia Pacific–15%, Latin America- 11%, and Middle east and Africa-10%
Note 2: C-level primaries include CEOs, CFOs, COOs, and VPs.
Note 3: Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.
The major players operating in the pharmaceutical drying equipment market market are GEA Group (Germany), ATS Corporation (US), Hosokawa Micron Group (Japan), Freund Corporation (Japan), I.M.A. Industria Macchine Automatiche S.p.A. (Italy), Syntegon Technology GmbH (Germany), BUCHI Labortechnik AG (Switzerland), OPTIMA packaging group GmbH (Germany), Mechatech Systems Ltd (Netherland), and BEW Engineering Limited (India).
Research Coverage
This report studies the pharmaceutical drying equipment market based on type, scale of operation,, end user and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five major regions (and the respective countries in these regions).
Reasons to Buy the Report
The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies for strengthening their market presence.
This report provides insights on the following pointers:
- Analysis of Key divers (The expansion of pharmaceutical manufacturing facilities to drive market growth, The increased demand for biopharmaceuticals to drive market, The rapid growth of the contact manufacturing companies to drive market), restraints (The demand for refurbished drying equipment is restraining the market) , Challenge (Higher maintenance of the pharmaceutical drying equipment is major challenge for the market), opportunity (Increasing competition in pharmaceutical manufacturing industry due to loss of various drugs' market exclusivity, High growth potential of emerging markets)
- Market Penetration: Comprehensive information on the product portfolios offered by the top players in the pain management devices market
- Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the pharmaceutical drying equipment market
- Market Development: Comprehensive information on lucrative emerging regions
- Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the pain management devices market
- Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players.
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
1.3.1 SEGMENTS AND REGIONS COVERED
1.3.2 INCLUSIONS & EXCLUSIONS
1.3.3 YEARS CONSIDERED
1.3.4 CURRENCY CONSIDERED
1.4 STAKEHOLDERS
1.5 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 Key objectives of secondary research
2.1.1.2 Key secondary sources
2.1.1.3 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key primary sources
2.1.2.2 Key objectives of primary research
2.1.2.3 Key data from primary sources
2.1.2.4 Key industry insights
2.2 MARKET SIZE ESTIMATION
2.2.1 SUPPLY-SIDE ANALYSIS (REVENUE SHARE ANALYSIS)
2.2.2 TOP-DOWN APPROACH
2.2.3 COMPANY PRESENTATIONS AND PRIMARY INTERVIEWS
2.2.4 DEMAND-SIDE ANALYSIS (USING PHARMACEUTICAL DRYING EQUIPMENT ADOPTION)
2.3 DATA TRIANGULATION
2.4 MARKET RANKING ANALYSIS
2.5 STUDY ASSUMPTIONS
2.6 RISK ASSESSMENT
2.7 RESEARCH LIMITATIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PHARMACEUTICAL DRYING EQUIPMENT MARKET OVERVIEW
4.2 NORTH AMERICA: PHARMACEUTICAL DRYING EQUIPMENT MARKET,
BY END USER, 2023
4.3 GEOGRAPHIC SNAPSHOT OF PHARMACEUTICAL DRYING EQUIPMENT MARKET,
2024–2029
4.4 PHARMACEUTICAL DRYING EQUIPMENT MARKET: REGIONAL MIX, 2022–2029
4.5 PHARMACEUTICAL DRYING EQUIPMENT MARKET: DEVELOPED VS. EMERGING MARKETS, 2024 VS. 2029 (USD MILLION)
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Expansion of pharmaceutical manufacturing facilities
5.2.1.2 High demand for biopharmaceuticals
5.2.1.3 Rapid growth of contract manufacturing and development companies
5.2.2 RESTRAINTS
5.2.2.1 Increased demand for refurbished drying equipment
5.2.3 OPPORTUNITIES
5.2.3.1 Increased market competition and high demand for generic and biosimilar drugs
5.2.3.2 High growth potential in emerging economies
5.2.4 CHALLENGES
5.2.4.1 Need for regular maintenance and high associated costs
5.3 INDUSTRY TRENDS
5.3.1 AUTOMATION AND DIGITALIZATION
5.3.2 ENVIRONMENTAL SUSTAINABILITY
5.4 TECHNOLOGY ANALYSIS
5.4.1 KEY TECHNOLOGIES
5.4.1.1 Automation and control systems
5.4.1.2 Heat transfer technology
5.4.1.3 Vacuum technology
5.4.2 COMPLEMENTARY TECHNOLOGIES
5.4.2.1 High-efficiency particulate air (HEPA) filtration technology
5.4.2.2 Temperature control systems
5.4.2.3 Desorption technology
5.4.3 ADJACENT TECHNOLOGIES
5.4.3.1 Moisture sensors and monitoring systems
5.4.3.2 Air distribution systems
5.4.3.3 Particle size analysis technology
5.5 PORTER’S FIVE FORCE ANALYSIS
5.5.1 INTENSITY OF COMPETITIVE RIVALRY
5.5.2 BARGAINING POWER OF SUPPLIERS
5.5.3 BARGAINING POWER OF BUYERS
5.5.4 THREAT OF SUBSTITUTES
5.5.5 THREAT OF NEW ENTRANTS
5.6 KEY STAKEHOLDERS AND BUYING CRITERIA
5.6.1 KEY STAKEHOLDERS IN BUYING PROCESS
5.6.2 KEY BUYING CRITERIA
5.7 REGULATORY LANDSCAPE
5.7.1 REGULATORY ANALYSIS
5.7.1.1 North America
5.7.1.1.1 US
5.7.1.1.2 Canada
5.7.1.2 Europe
5.7.1.3 Asia Pacific
5.7.1.4 Latin America
5.7.1.5 Middle East & Africa
5.7.2 REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS
5.8 PATENT ANALYSIS
5.8.1 PATENT PUBLICATION TRENDS IN PHARMACEUTICAL DRYING EQUIPMENT MARKET
5.8.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
5.9 TRADE ANALYSIS
5.9.1 IMPORT DATA FOR HS CODE 8419
5.9.2 EXPORT DATA FOR HS CODE 8419
5.10 PRICING ANALYSIS
5.10.1 INDICATIVE SELLING PRICE OF DRYERS, BY PRODUCT
5.10.2 INDICATIVE SELLING PRICE OF DRYERS, BY REGION
5.11 KEY CONFERENCES AND EVENTS, 2024–2025
5.12 UNMET NEEDS
5.13 END-USER EXPECTATIONS
5.14 IMPACT OF AI/GENERATIVE AI ON PHARMACEUTICAL DRYING EQUIPMENT MARKET
5.14.1 KEY USE CASES
5.15 ECOSYSTEM ANALYSIS
5.16 CASE STUDY ANALYSIS
5.16.1 CASE STUDY 1: IMPROVED VACUUM PRESSURE TO REDUCE DRYING TIME, INCREASE QUALITY, AND SAVE PRODUCTION COSTS
5.16.2 CASE STUDY 2: OPTIMIZED PARTICLE SIZE DISTRIBUTION FOR HIGH-POTENCY API PRODUCTION
5.16.3 CASE STUDY 3: INNOVATIVE CONTAINMENT SOLUTIONS FOR HIGH-POTENCY APIS TO ENHANCE NUTSCHE FILTER DRYER PERFORMANCE
5.17 SUPPLY CHAIN ANALYSIS
5.18 ADJACENT MARKET ANALYSIS
5.18.1 SPRAY DRYING EQUIPMENT MARKET
5.19 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
5.20 INVESTMENT AND FUNDING SCENARIO
6 PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY TYPE
6.1 INTRODUCTION
6.2 SPRAY DRYERS
6.2.1 ABILITY TO MAINTAIN STABILITY OF THERMALLY SENSITIVE COMPOUNDS THROUGH RAPID DRYING TO PRESERVE DRUG EFFICACY
6.3 FREEZE DRYERS
6.3.1 RISING DEMAND FOR LYOPHILIZED PRODUCTS TO DRIVE MARKET
6.4 FLUIDIZED BED DRYERS
6.4.1 COST-EFFECTIVENESS AND UNIFORM DRYING TO SPUR DEMAND IN PHARMACEUTICAL MANUFACTURING FACILITIES
6.5 VACUUM DRYERS
6.5.1 VACUUM DRYERS TO MINIMIZE THERMAL DEGRADATION AND PROVIDE STABILITY TO HEAT-SENSITIVE MATERIALS
6.6 OTHER DRYERS
7 PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY SCALE OF OPERATION
7.1 INTRODUCTION
7.2 INDUSTRIAL-SCALE EQUIPMENT
7.2.1 RISING INVESTMENTS IN HIGH-QUALITY MANUFACTURING TO AUGMENT MARKET GROWTH
7.3 PILOT-SCALE EQUIPMENT
7.3.1 INCREASED PHARMACEUTICAL R&D INVESTMENTS AND FOCUS ON EFFECTIVE QUALITY CONTROL IN LARGER OPERATIONS TO DRIVE MARKET
7.4 LABORATORY-SCALE EQUIPMENT
7.4.1 COST-EFFECTIVENESS, EASY OPERATION, AND LOW MAINTENANCE NEEDS TO FUEL MARKET GROWTH
8 PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY END USER
8.1 INTRODUCTION
8.2 PHARMACEUTICAL AND BIOTECH COMPANIES
8.2.1 INCREASED INVESTMENTS FOR BETTER PRODUCTION EFFICIENCY IN PHARMACEUTICAL INDUSTRY TO DRIVE MARKET
8.3 CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS
8.3.1 INCREASED OUTSOURCING OF RESEARCH AND MANUFACTURING PROCESSES BY PHARMA COMPANIES TO PROPEL MARKET GROWTH
8.4 RESEARCH ACADEMIES AND UNIVERSITIES
8.4.1 RISING DEMAND FOR ADVANCED LABORATORY AND RESEARCH FACILITIES IN ACADEMIC SETTINGS TO DRIVE MARKET
9 PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY REGION
9.1 INTRODUCTION
9.2 NORTH AMERICA
9.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
9.2.2 US
9.2.2.1 US to dominate North American pharmaceutical drying equipment market during forecast period
9.2.3 CANADA
9.2.3.1 Robust pharmaceutical sector and advancements in drug development to aid market growth
9.3 EUROPE
9.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
9.3.2 GERMANY
9.3.2.1 Increased R&D investments by key players and technological advancements to support market growth
9.3.3 FRANCE
9.3.3.1 Rising investments in bioproduction capacities to spur market growth
9.3.4 ITALY
9.3.4.1 Growing demand for biologics and biopharmaceuticals to boost market growth
9.3.5 UK
9.3.5.1 Increased government investments in pharmaceuticals and clinical trials to propel market growth
9.3.6 SPAIN
9.3.6.1 Increasing collaborations between drying equipment manufacturing companies to aid market growth
9.3.7 REST OF EUROPE
9.4 ASIA PACIFIC
9.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
9.4.2 CHINA
9.4.2.1 Technological advancements and strategic expansions by key international players to augment market growth
9.4.3 JAPAN
9.4.3.1 High investments in manufacturing capabilities and increased geriatric population to aid market growth
9.4.4 INDIA
9.4.4.1 Increasing investments in manufacturing facilities to propel market growth
9.4.5 AUSTRALIA
9.4.5.1 Rising demand for pharmaceuticals and increasing advancements in drug formulations to drive market
9.4.6 SOUTH KOREA
9.4.6.1 Increased popularity of CDMOs for pharmaceutical production to fuel market growth
9.4.7 REST OF ASIA PACIFIC
9.5 LATIN AMERICA
9.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
9.5.2 BRAZIL
9.5.2.1 Advanced biologics sector and increased demand for biosimilars to drive market
9.5.3 MEXICO
9.5.3.1 Burgeoning pharmaceutical industry and favorable trade agreements to propel market growth
9.5.4 REST OF LATIN AMERICA
9.6 MIDDLE EAST & AFRICA
9.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
9.6.2 GCC COUNTRIES
9.6.2.1 Expansion of pharmaceutical manufacturing companies to drive market
9.6.3 REST OF MIDDLE EAST & AFRICA
10 COMPETITIVE LANDSCAPE
10.1 INTRODUCTION
10.2 KEY PLAYER STRATEGY/RIGHT TO WIN
10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN PHARMACEUTICAL DRYING EQUIPMENT MARKET
10.3 REVENUE ANALYSIS, 2021–2023
10.4 MARKET SHARE ANALYSIS, 2023
10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
10.5.1 STARS
10.5.2 EMERGING LEADERS
10.5.3 PERVASIVE PLAYERS
10.5.4 PARTICIPANTS
10.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
10.5.5.1 Company footprint
10.5.5.2 Type footprint
10.5.5.3 Scale of operation footprint
10.5.5.4 End-user footprint
10.5.5.5 Region footprint
10.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
10.6.1 PROGRESSIVE COMPANIES
10.6.2 RESPONSIVE COMPANIES
10.6.3 DYNAMIC COMPANIES
10.6.4 STARTING BLOCKS
10.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
10.7 COMPANY VALUATION AND FINANCIAL METRICS
10.7.1 FINANCIAL METRICS
10.7.2 COMPANY VALUATION
10.8 BRAND/PRODUCT COMPARISON
10.9 COMPETITIVE SCENARIO
10.9.1 PRODUCT LAUNCHES
10.9.2 DEALS
10.9.3 EXPANSIONS
11 COMPANY PROFILES
11.1 KEY PLAYERS
11.1.1 GEA GROUP AKTIENGESELLSCHAFT
11.1.1.1 Business overview
11.1.1.2 Products offered
11.1.1.3 Recent developments
11.1.1.3.1 Deals
11.1.1.4 MnM view
11.1.1.4.1 Right to win
11.1.1.4.2 Strategic choices
11.1.1.4.3 Weaknesses and competitive threats
11.1.2 IMA INDUSTRIA MACCHINE AUTOMATICHE SPA
11.1.2.1 Business overview
11.1.2.2 Products offered
11.1.2.3 MnM view
11.1.2.3.1 Right to win
11.1.2.3.2 Strategic choices
11.1.2.3.3 Weaknesses and competitive threats
11.1.3 ATS CORPORATION
11.1.3.1 Business overview
11.1.3.2 Products offered
11.1.3.3 Recent developments
11.1.3.3.1 Product launches
11.1.3.3.2 Deals
11.1.3.3.3 Expansions
11.1.3.4 MnM view
11.1.3.4.1 Right to win
11.1.3.4.2 Strategic choices
11.1.3.4.3 Weaknesses and competitive threats
11.1.4 HOSOKAWA MICRON GROUP
11.1.4.1 Business overview
11.1.4.2 Products offered
11.1.4.3 MnM view
11.1.4.3.1 Right to win
11.1.4.3.2 Strategic choices
11.1.4.3.3 Weaknesses and competitive threats
11.1.5 FREUND CORP.
11.1.5.1 Business overview
11.1.5.2 Products offered
11.1.6 SYNTEGON TECHNOLOGY GMBH
11.1.6.1 Business overview
11.1.6.2 Products offered
11.1.6.3 Recent developments
11.1.6.3.1 Deals
11.1.7 BЬCHI LABORTECHNIK AG
11.1.7.1 Business overview
11.1.7.2 Products offered
11.1.7.3 Recent developments
11.1.7.3.1 Product launches
11.1.8 OPTIMA
11.1.8.1 Business overview
11.1.8.2 Products offered
11.1.9 MECHATECH SYSTEMS LTD.
11.1.9.1 Business overview
11.1.9.2 Products offered
11.1.10 BEW ENGINEERING
11.1.10.1 Business overview
11.1.10.2 Products offered
11.2 OTHER PLAYERS
11.2.1 ZIRBUS TECHNOLOGY GMBH
11.2.2 SPX FLOW, INC.
11.2.3 EUROPEAN SPRAYDRY TECHNOLOGIES
11.2.4 YAMATO SCIENTIFIC CO., LTD.
11.2.5 SAKA
11.2.6 ILSHIN BIOBASE
11.2.7 OKAWARA MFG. CO., LTD.
11.2.8 CHANGZHOU CHANGJIANG DRYING EQUIPMENT CO., LTD.
11.2.9 BACHILLER
11.2.10 MILLROCK TECHNOLOGY, INC.
11.2.11 MARTIN CHRIST GEFRIERTROCKNUNGSANLAGEN GMBH
11.2.12 LABCONCO
11.2.13 O’HARA TECHNOLOGIES
11.2.14 COOLVACUUM TECHNOLOGIES, SL
11.2.15 SHACHI ENGINEERING PVT. LTD.
12 APPENDIX
12.1 DISCUSSION GUIDE
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.3 CUSTOMIZATION OPTIONS
12.4 RELATED REPORTS
12.5 AUTHOR DETAILS
TABLE 1 PHARMACEUTICAL DRYING EQUIPMENT MARKET: INCLUSIONS & EXCLUSIONS
TABLE 2 CURRENCY CONVERSION RATES
TABLE 3 PHARMACEUTICAL DRYING EQUIPMENT MARKET: STUDY ASSUMPTIONS
TABLE 4 PHARMACEUTICAL DRYING EQUIPMENT MARKET: RISK ASSESSMENT
TABLE 5 PHARMACEUTICAL DRYING EQUIPMENT MARKET: PORTER’S FIVE FORCES
TABLE 6 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS FOR PHARMACEUTICAL DRYING EQUIPMENT
TABLE 7 KEY BUYING CRITERIA FOR PHARMACEUTICAL DRYING EQUIPMENT
TABLE 8 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS
TABLE 9 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS
TABLE 10 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS
TABLE 11 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS
TABLE 12 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT
AGENCIES, AND OTHER ORGANIZATIONS
TABLE 13 LIST OF PATENTS IN PHARMACEUTICAL DRYING EQUIPMENT MARKET, 2014?2024
TABLE 14 IMPORT DATA FOR HS CODE 8419, BY COUNTRY, 2018–2023 (USD MILLION)
TABLE 15 EXPORT DATA FOR HS CODE 8419, BY COUNTRY, 2018–2023 (USD MILLION)
TABLE 16 INDICATIVE SELLING PRICING OF DRYERS, 2021–2023
TABLE 17 INDICATIVE SELLING PRICE OF DRYERS, BY REGION, 2022–2024
TABLE 18 PHARMACEUTICAL DRYING EQUIPMENT MARKET: KEY CONFERENCES AND EVENTS, JANUARY 2024–DECEMBER 2025
TABLE 19 PHARMACEUTICAL DRYING EQUIPMENT MARKET: UNMET NEEDS
TABLE 20 PHARMACEUTICAL DRYING EQUIPMENT MARKET: END-USER EXPECTATIONS
TABLE 21 PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 22 SPRAY DRYERS OFFERED BY KEY PLAYERS
TABLE 23 PHARMACEUTICAL DRYING EQUIPMENT MARKET FOR SPRAY DRYERS,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 24 FREEZE DRYERS OFFERED BY KEY PLAYERS
TABLE 25 PHARMACEUTICAL DRYING EQUIPMENT MARKET FOR FREEZE DRYERS,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 26 FLUIDIZED BED DRYERS OFFERED BY KEY PLAYERS
TABLE 27 PHARMACEUTICAL DRYING EQUIPMENT MARKET FOR FLUIDIZED BED DRYERS,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 28 VACUUM DRYERS OFFERED BY KEY PLAYERS
TABLE 29 PHARMACEUTICAL DRYING EQUIPMENT MARKET FOR VACUUM DRYERS,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 30 PHARMACEUTICAL DRYING EQUIPMENT MARKET FOR OTHER DRYERS,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 31 OTHER DRYERS OFFERED BY KEY PLAYERS
TABLE 32 PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION)
TABLE 33 PHARMACEUTICAL DRYING EQUIPMENT MARKET FOR INDUSTRIAL-SCALE EQUIPMENT, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 34 PHARMACEUTICAL DRYING EQUIPMENT MARKET FOR PILOT-SCALE EQUIPMENT, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 35 PHARMACEUTICAL DRYING EQUIPMENT MARKET FOR LABORATORY-SCALE EQUIPMENT, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 36 PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY END USER,
2022–2029 (USD MILLION)
TABLE 37 PHARMACEUTICAL DRYING EQUIPMENT MARKET FOR PHARMACEUTICAL AND BIOTECH COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 38 PHARMACEUTICAL DRYING EQUIPMENT MARKET FOR CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 39 PHARMACEUTICAL DRYING EQUIPMENT MARKET FOR RESEARCH ACADEMIES AND UNIVERSITIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 40 PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY REGION,
2022–2029 (USD MILLION)
TABLE 41 NORTH AMERICA: PHARMACEUTICAL DRYING EQUIPMENT MARKET,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 42 NORTH AMERICA: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 43 NORTH AMERICA: PHARMACEUTICAL DRYING EQUIPMENT MARKET,
BY SCALE OF OPERATION, 2022–2029 (USD MILLION)
TABLE 44 NORTH AMERICA: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 45 US: KEY MACROINDICATORS
TABLE 46 US: PHARMACEUTICAL INDUSTRY LANDSCAPE
TABLE 47 US: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 48 US: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY SCALE
OF OPERATION, 2022–2029 (USD MILLION)
TABLE 49 US: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY END USER,
2022–2029 (USD MILLION)
TABLE 50 CANADA: KEY MACROINDICATORS
TABLE 51 CANADA: PHARMACEUTICAL INDUSTRY LANDSCAPE
TABLE 52 TOP FIVE EXPORTERS OF PHARMACEUTICAL PRODUCTS TO CANADA
TABLE 53 CANADA: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 54 CANADA: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION)
TABLE 55 CANADA: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY END USER,
2022–2029 (USD MILLION)
TABLE 56 EUROPE: PHARMACEUTICAL INDUSTRY LANDSCAPE
TABLE 57 EUROPE: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 58 EUROPE: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 59 EUROPE: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION)
TABLE 60 EUROPE: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY END USER,
2022–2029 (USD MILLION)
TABLE 61 GERMANY: KEY MACROINDICATORS
TABLE 62 GERMANY: PHARMACEUTICAL INDUSTRY LANDSCAPE
TABLE 63 GERMANY: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 64 GERMANY: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION)
TABLE 65 GERMANY: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 66 FRANCE: KEY MACROINDICATORS
TABLE 67 FRANCE: PHARMACEUTICAL INDUSTRY LANDSCAPE
TABLE 68 FRANCE: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 69 FRANCE: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION)
TABLE 70 FRANCE: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY END USER,
2022–2029 (USD MILLION)
TABLE 71 ITALY: KEY MACROINDICATORS
TABLE 72 ITALY: PHARMACEUTICAL INDUSTRY LANDSCAPE
TABLE 73 ITALY: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 74 ITALY: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION)
TABLE 75 ITALY: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY END USER,
2022–2029 (USD MILLION)
TABLE 76 UK: KEY MACROINDICATORS
TABLE 77 UK: PHARMACEUTICAL INDUSTRY LANDSCAPE
TABLE 78 UK: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 79 UK: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION)
TABLE 80 UK: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY END USER,
2022–2029 (USD MILLION)
TABLE 81 SPAIN: KEY MACROINDICATORS
TABLE 82 SPAIN: PHARMACEUTICAL INDUSTRY LANDSCAPE
TABLE 83 SPAIN: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 84 SPAIN: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION)
TABLE 85 SPAIN: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY END USER,
2022–2029 (USD MILLION)
TABLE 86 SWITZERLAND: PHARMACEUTICAL INDUSTRY LANDSCAPE
TABLE 87 POLAND: PHARMACEUTICAL INDUSTRY LANDSCAPE
TABLE 88 BELGIUM: PHARMACEUTICAL PRODUCTION VALUE (USD MILLION)
TABLE 89 AUSTRIA: PHARMACEUTICAL PRODUCTION VALUE (USD MILLION)
TABLE 90 IRELAND: PHARMACEUTICAL INDUSTRY LANDSCAPE
TABLE 91 REST OF EUROPE: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 92 REST OF EUROPE: PHARMACEUTICAL DRYING EQUIPMENT MARKET,
BY SCALE OF OPERATION, 2022–2029 (USD MILLION)
TABLE 93 REST OF EUROPE: PHARMACEUTICAL DRYING EQUIPMENT MARKET,
BY END USER, 2022–2029 (USD MILLION)
TABLE 94 ASIA PACIFIC: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 95 ASIA PACIFIC: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 96 ASIA PACIFIC: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION)
TABLE 97 ASIA PACIFIC: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 98 CHINA: KEY MACROINDICATORS
TABLE 99 CHINA: PHARMACEUTICAL INDUSTRY LANDSCAPE
TABLE 100 CHINA: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 101 CHINA: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION)
TABLE 102 CHINA: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY END USER,
2022–2029 (USD MILLION)
TABLE 103 JAPAN: KEY MACROINDICATORS
TABLE 104 JAPAN: PHARMACEUTICAL INDUSTRY LANDSCAPE
TABLE 105 JAPAN: PHARMACEUTICAL PRODUCTION, BY DOSAGE FORM
TABLE 106 JAPAN: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 107 JAPAN: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION)
TABLE 108 JAPAN: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY END USER,
2022–2029 (USD MILLION)
TABLE 109 INDIA: KEY MACROINDICATORS
TABLE 110 INDIA: PHARMACEUTICAL INDUSTRY LANDSCAPE
TABLE 111 INDIA: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 112 INDIA: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION)
TABLE 113 INDIA: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY END USER,
2022–2029 (USD MILLION)
TABLE 114 AUSTRALIA: KEY MACROINDICATORS
TABLE 115 AUSTRALIA: PHARMACEUTICAL INDUSTRY LANDSCAPE
TABLE 116 AUSTRALIA: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 117 AUSTRALIA: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION)
TABLE 118 AUSTRALIA: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 119 SOUTH KOREA: KEY MACROINDICATORS
TABLE 120 SOUTH KOREA: PHARMACEUTICAL MANUFACTURERS SIZE
TABLE 121 SOUTH KOREA: PHARMACEUTICAL PRODUCTION VALUE (USD BILLION)
TABLE 122 SOUTH KOREA: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 123 SOUTH KOREA: PHARMACEUTICAL DRYING EQUIPMENT MARKET,
BY SCALE OF OPERATION, 2022–2029 (USD MILLION)
TABLE 124 SOUTH KOREA: PHARMACEUTICAL DRYING EQUIPMENT MARKET,
BY END USER, 2022–2029 (USD MILLION)
TABLE 125 SINGAPORE: PHARMACEUTICAL INDUSTRY LANDSCAPE
TABLE 126 SINGAPORE: PHARMACEUTICAL AND BIOLOGICAL PRODUCTION INDEX
(2019–2023)
TABLE 127 MALAYSIA: PHARMACEUTICAL INDUSTRY LANDSCAPE
TABLE 128 REST OF ASIA PACIFIC: PHARMACEUTICAL DRYING EQUIPMENT MARKET,
BY TYPE, 2022–2029 (USD MILLION)
TABLE 129 REST OF ASIA PACIFIC: PHARMACEUTICAL DRYING EQUIPMENT MARKET,
BY SCALE OF OPERATION, 2022–2029 (USD MILLION)
TABLE 130 REST OF ASIA PACIFIC: PHARMACEUTICAL DRYING EQUIPMENT MARKET,
BY END USER, 2022–2029 (USD MILLION)
TABLE 131 LATIN AMERICA: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 132 LATIN AMERICA: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 133 LATIN AMERICA: PHARMACEUTICAL DRYING EQUIPMENT MARKET,
BY SCALE OF OPERATION, 2022–2029 (USD MILLION)
TABLE 134 LATIN AMERICA: PHARMACEUTICAL DRYING EQUIPMENT MARKET,
BY END USER, 2022–2029 (USD MILLION)
TABLE 135 BRAZIL: KEY MACROINDICATORS
TABLE 136 BRAZIL: PHARMACEUTICAL INDUSTRY LANDSCAPE
TABLE 137 BRAZIL: IMPORT VALUE OF PHARMACEUTICAL PRODUCTS (2020–2023)
TABLE 138 BRAZIL: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 139 BRAZIL: PHARMACEUTICAL DRYING EQUIPMENT MARKET,
BY SCALE OF OPERATION, 2022–2029 (USD MILLION)
TABLE 140 BRAZIL: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY END USER,
2022–2029 (USD MILLION)
TABLE 141 MEXICO: KEY MACROINDICATORS
TABLE 142 MEXICO: PHARMACEUTICAL INDUSTRY LANDSCAPE
TABLE 143 MEXICO: PHARMACEUTICAL PRODUCTS IMPORT-EXPORT VALUE (2020–2023)
TABLE 144 MEXICO: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 145 MEXICO: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION)
TABLE 146 MEXICO: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY END USER,
2022–2029 (USD MILLION)
TABLE 147 ARGENTINA: PHARMACEUTICAL INDUSTRY LANDSCAPE
TABLE 148 ARGENTINA: PHARMACEUTICAL PRODUCTS IMPORT-EXPORT VALUE
TABLE 149 REST OF LATIN AMERICA: PHARMACEUTICAL DRYING EQUIPMENT MARKET,
BY TYPE, 2022–2029 (USD MILLION)
TABLE 150 REST OF LATIN AMERICA: PHARMACEUTICAL DRYING EQUIPMENT MARKET,
BY SCALE OF OPERATION, 2022–2029 (USD MILLION)
TABLE 151 REST OF LATIN AMERICA: PHARMACEUTICAL DRYING EQUIPMENT MARKET,
BY END USER, 2022–2029 (USD MILLION)
TABLE 152 MIDDLE EAST & AFRICA: PHARMACEUTICAL DRYING EQUIPMENT MARKET,
BY REGION, 2022–2029 (USD MILLION)
TABLE 153 MIDDLE EAST & AFRICA: PHARMACEUTICAL DRYING EQUIPMENT MARKET,
BY TYPE, 2022–2029 (USD MILLION)
TABLE 154 MIDDLE EAST & AFRICA: PHARMACEUTICAL DRYING EQUIPMENT MARKET,
BY SCALE OF OPERATION, 2022–2029 (USD MILLION)
TABLE 155 MIDDLE EAST & AFRICA: PHARMACEUTICAL DRYING EQUIPMENT MARKET,
BY END USER, 2022–2029 (USD MILLION)
TABLE 156 UAE: GROWTH RATE OF PHARMACEUTICAL MANUFACTURING PLANT,
2010 VS. 2021
TABLE 157 SAUDI ARABIA: PHARMACEUTICAL INDUSTRY LANDSCAPE
TABLE 158 GCC COUNTRIES: PHARMACEUTICAL DRYING EQUIPMENT MARKET,
BY TYPE, 2022–2029 (USD MILLION)
TABLE 159 GCC COUNTRIES: PHARMACEUTICAL DRYING EQUIPMENT MARKET,
BY SCALE OF OPERATION, 2022–2029 (USD MILLION)
TABLE 160 GCC COUNTRIES: PHARMACEUTICAL DRYING EQUIPMENT MARKET,
BY END USER, 2022–2029 (USD MILLION)
TABLE 161 REST OF MIDDLE EAST & AFRICA: PHARMACEUTICAL INDUSTRY LANDSCAPE
TABLE 162 SOUTH AFRICA: PHARMACEUTICAL PRODUCTS IMPORT-EXPORT VALUE
TABLE 163 EGYPT: PHARMACEUTICAL PRODUCTS IMPORT-EXPORT VALUE
TABLE 164 GHANA: PHARMACEUTICAL PRODUCTS IMPORT-EXPORT VALUE
TABLE 165 KENYA: PHARMACEUTICAL PRODUCTS IMPORT-EXPORT VALUE
TABLE 166 ETHIOPIA: PHARMACEUTICAL PRODUCTS IMPORT-EXPORT VALUE
TABLE 167 REST OF MIDDLE EAST & AFRICA: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 168 REST OF MIDDLE EAST & AFRICA: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION)
TABLE 169 REST OF MIDDLE EAST & AFRICA: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 170 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN PHARMACEUTICAL DRYING EQUIPMENT MARKET
TABLE 171 PHARMACEUTICAL DRYING EQUIPMENT MARKET: DEGREE OF COMPETITION
TABLE 172 PHARMACEUTICAL DRYING EQUIPMENT MARKET: TYPE FOOTPRINT
TABLE 173 PHARMACEUTICAL DRYING EQUIPMENT MARKET:
SCALE OF OPERATION FOOTPRINT
TABLE 174 PHARMACEUTICAL DRYING EQUIPMENT MARKET: END-USER FOOTPRINT
TABLE 175 PHARMACEUTICAL DRYING EQUIPMENT MARKET: REGION FOOTPRINT
TABLE 176 PHARMACEUTICAL DRYING EQUIPMENT MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYER
TABLE 177 PHARMACEUTICAL DRYING EQUIPMENT MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS
TABLE 178 PHARMACEUTICAL DRYING EQUIPMENT MARKET: PRODUCT LAUNCHES, JANUARY 2021–AUGUST 2024
TABLE 179 PHARMACEUTICAL DRYING EQUIPMENT MARKET: DEALS,
JANUARY 2021–AUGUST 2024
TABLE 180 PHARMACEUTICAL DRYING EQUIPMENT MARKET: EXPANSIONS,
JANUARY 2021–AUGUST 2024
TABLE 181 GEA GROUP AKTIENGESELLSCHAFT: COMPANY OVERVIEW
TABLE 182 GEA GROUP AKTIENGESELLSCHAFT: PRODUCTS OFFERED
TABLE 183 GEA GROUP AKTIENGESELLSCHAFT: DEALS, JANUARY 2021–AUGUST 2024
TABLE 184 IMA INDUSTRIA MACCHINE AUTOMATICHE SPA: COMPANY OVERVIEW
TABLE 185 IMA INDUSTRIA MACCHINE AUTOMATICHE SPA: PRODUCTS OFFERED
TABLE 186 ATS CORPORATION: COMPANY OVERVIEW
TABLE 187 ATS CORPORATION: PRODUCTS OFFERED
TABLE 188 ATS CORPORATION PRODUCT LAUNCHES, JANUARY 2021–AUGUST 2024
TABLE 189 ATS CORPORATION: DEALS, JANUARY 2021–AUGUST 2024
TABLE 190 ATS CORPORATION: EXPANSIONS, JANUARY 2021–AUGUST 2024
TABLE 191 HOSOKAWA MICRON GROUP: COMPANY OVERVIEW
TABLE 192 HOSOKAWA MICRON GROUP: PRODUCTS OFFERED
TABLE 193 FREUND CORP.: COMPANY OVERVIEW
TABLE 194 FREUND CORP.: PRODUCTS OFFERED
TABLE 195 SYNTEGON TECHNOLOGY GMBH: COMPANY OVERVIEW
TABLE 196 SYNTEGON TECHNOLOGY GMBH: PRODUCTS OFFERED
TABLE 197 SYNTEGON TECHNOLOGY GMBH: DEALS, JANUARY 2021–AUGUST 2024
TABLE 198 BЬCHI LABORTECHNIK AG.: COMPANY OVERVIEW
TABLE 199 BЬCHI LABORTECHNIK AG: PRODUCTS OFFERED
TABLE 200 BЬCHI LABORTECHNIK AG: PRODUCT LAUNCHES, JANUARY 2021–AUGUST 2024
TABLE 201 OPTIMA: COMPANY OVERVIEW
TABLE 202 OPTIMA: PRODUCTS OFFERED
TABLE 203 MECHATECH SYSTEMS LTD.: COMPANY OVERVIEW
TABLE 204 MECHATECH SYSTEMS LTD.: PRODUCTS OFFERED
TABLE 205 BEW ENGINEERING: COMPANY OVERVIEW
TABLE 206 BEW ENGINEERING: PRODUCTS OFFERED
TABLE 207 ZIRBUS TECHNOLOGY GMBH: COMPANY OVERVIEW
TABLE 208 SPX FLOW, INC.: COMPANY OVERVIEW
TABLE 209 EUROPEAN SPRAYDRY TECHNOLOGIES: COMPANY OVERVIEW
TABLE 210 YAMATO SCIENTIFIC CO., LTD.: COMPANY OVERVIEW
TABLE 211 SAKA: COMPANY OVERVIEW
TABLE 212 ILSHIN BIOBASE: COMPANY OVERVIEW
TABLE 213 OKAWARA MFG. CO., LTD.: COMPANY OVERVIEW
TABLE 214 CHANGZHOU CHANGJIANG DRYING EQUIPMENT CO., LTD.: COMPANY OVERVIEW
TABLE 215 BACHILLER: COMPANY OVERVIEW
TABLE 216 MILLROCK TECHNOLOGY, INC.: COMPANY OVERVIEW
TABLE 217 MARTIN CHRIST GEFRIERTROCKNUNGSANLAGEN GMBH: COMPANY OVERVIEW
TABLE 218 LABCONCO: COMPANY OVERVIEW
TABLE 219 O’HARA TECHNOLOGIES: COMPANY OVERVIEW
TABLE 220 COOLVACUUM TECHNOLOGIES, SL: COMPANY OVERVIEW
TABLE 221 SHACHI ENGINEERING PVT. LTD.: COMPANY OVERVIEW
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
1.3.1 SEGMENTS AND REGIONS COVERED
1.3.2 INCLUSIONS & EXCLUSIONS
1.3.3 YEARS CONSIDERED
1.3.4 CURRENCY CONSIDERED
1.4 STAKEHOLDERS
1.5 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 Key objectives of secondary research
2.1.1.2 Key secondary sources
2.1.1.3 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key primary sources
2.1.2.2 Key objectives of primary research
2.1.2.3 Key data from primary sources
2.1.2.4 Key industry insights
2.2 MARKET SIZE ESTIMATION
2.2.1 SUPPLY-SIDE ANALYSIS (REVENUE SHARE ANALYSIS)
2.2.2 TOP-DOWN APPROACH
2.2.3 COMPANY PRESENTATIONS AND PRIMARY INTERVIEWS
2.2.4 DEMAND-SIDE ANALYSIS (USING PHARMACEUTICAL DRYING EQUIPMENT ADOPTION)
2.3 DATA TRIANGULATION
2.4 MARKET RANKING ANALYSIS
2.5 STUDY ASSUMPTIONS
2.6 RISK ASSESSMENT
2.7 RESEARCH LIMITATIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PHARMACEUTICAL DRYING EQUIPMENT MARKET OVERVIEW
4.2 NORTH AMERICA: PHARMACEUTICAL DRYING EQUIPMENT MARKET,
BY END USER, 2023
4.3 GEOGRAPHIC SNAPSHOT OF PHARMACEUTICAL DRYING EQUIPMENT MARKET,
2024–2029
4.4 PHARMACEUTICAL DRYING EQUIPMENT MARKET: REGIONAL MIX, 2022–2029
4.5 PHARMACEUTICAL DRYING EQUIPMENT MARKET: DEVELOPED VS. EMERGING MARKETS, 2024 VS. 2029 (USD MILLION)
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Expansion of pharmaceutical manufacturing facilities
5.2.1.2 High demand for biopharmaceuticals
5.2.1.3 Rapid growth of contract manufacturing and development companies
5.2.2 RESTRAINTS
5.2.2.1 Increased demand for refurbished drying equipment
5.2.3 OPPORTUNITIES
5.2.3.1 Increased market competition and high demand for generic and biosimilar drugs
5.2.3.2 High growth potential in emerging economies
5.2.4 CHALLENGES
5.2.4.1 Need for regular maintenance and high associated costs
5.3 INDUSTRY TRENDS
5.3.1 AUTOMATION AND DIGITALIZATION
5.3.2 ENVIRONMENTAL SUSTAINABILITY
5.4 TECHNOLOGY ANALYSIS
5.4.1 KEY TECHNOLOGIES
5.4.1.1 Automation and control systems
5.4.1.2 Heat transfer technology
5.4.1.3 Vacuum technology
5.4.2 COMPLEMENTARY TECHNOLOGIES
5.4.2.1 High-efficiency particulate air (HEPA) filtration technology
5.4.2.2 Temperature control systems
5.4.2.3 Desorption technology
5.4.3 ADJACENT TECHNOLOGIES
5.4.3.1 Moisture sensors and monitoring systems
5.4.3.2 Air distribution systems
5.4.3.3 Particle size analysis technology
5.5 PORTER’S FIVE FORCE ANALYSIS
5.5.1 INTENSITY OF COMPETITIVE RIVALRY
5.5.2 BARGAINING POWER OF SUPPLIERS
5.5.3 BARGAINING POWER OF BUYERS
5.5.4 THREAT OF SUBSTITUTES
5.5.5 THREAT OF NEW ENTRANTS
5.6 KEY STAKEHOLDERS AND BUYING CRITERIA
5.6.1 KEY STAKEHOLDERS IN BUYING PROCESS
5.6.2 KEY BUYING CRITERIA
5.7 REGULATORY LANDSCAPE
5.7.1 REGULATORY ANALYSIS
5.7.1.1 North America
5.7.1.1.1 US
5.7.1.1.2 Canada
5.7.1.2 Europe
5.7.1.3 Asia Pacific
5.7.1.4 Latin America
5.7.1.5 Middle East & Africa
5.7.2 REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS
5.8 PATENT ANALYSIS
5.8.1 PATENT PUBLICATION TRENDS IN PHARMACEUTICAL DRYING EQUIPMENT MARKET
5.8.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
5.9 TRADE ANALYSIS
5.9.1 IMPORT DATA FOR HS CODE 8419
5.9.2 EXPORT DATA FOR HS CODE 8419
5.10 PRICING ANALYSIS
5.10.1 INDICATIVE SELLING PRICE OF DRYERS, BY PRODUCT
5.10.2 INDICATIVE SELLING PRICE OF DRYERS, BY REGION
5.11 KEY CONFERENCES AND EVENTS, 2024–2025
5.12 UNMET NEEDS
5.13 END-USER EXPECTATIONS
5.14 IMPACT OF AI/GENERATIVE AI ON PHARMACEUTICAL DRYING EQUIPMENT MARKET
5.14.1 KEY USE CASES
5.15 ECOSYSTEM ANALYSIS
5.16 CASE STUDY ANALYSIS
5.16.1 CASE STUDY 1: IMPROVED VACUUM PRESSURE TO REDUCE DRYING TIME, INCREASE QUALITY, AND SAVE PRODUCTION COSTS
5.16.2 CASE STUDY 2: OPTIMIZED PARTICLE SIZE DISTRIBUTION FOR HIGH-POTENCY API PRODUCTION
5.16.3 CASE STUDY 3: INNOVATIVE CONTAINMENT SOLUTIONS FOR HIGH-POTENCY APIS TO ENHANCE NUTSCHE FILTER DRYER PERFORMANCE
5.17 SUPPLY CHAIN ANALYSIS
5.18 ADJACENT MARKET ANALYSIS
5.18.1 SPRAY DRYING EQUIPMENT MARKET
5.19 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
5.20 INVESTMENT AND FUNDING SCENARIO
6 PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY TYPE
6.1 INTRODUCTION
6.2 SPRAY DRYERS
6.2.1 ABILITY TO MAINTAIN STABILITY OF THERMALLY SENSITIVE COMPOUNDS THROUGH RAPID DRYING TO PRESERVE DRUG EFFICACY
6.3 FREEZE DRYERS
6.3.1 RISING DEMAND FOR LYOPHILIZED PRODUCTS TO DRIVE MARKET
6.4 FLUIDIZED BED DRYERS
6.4.1 COST-EFFECTIVENESS AND UNIFORM DRYING TO SPUR DEMAND IN PHARMACEUTICAL MANUFACTURING FACILITIES
6.5 VACUUM DRYERS
6.5.1 VACUUM DRYERS TO MINIMIZE THERMAL DEGRADATION AND PROVIDE STABILITY TO HEAT-SENSITIVE MATERIALS
6.6 OTHER DRYERS
7 PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY SCALE OF OPERATION
7.1 INTRODUCTION
7.2 INDUSTRIAL-SCALE EQUIPMENT
7.2.1 RISING INVESTMENTS IN HIGH-QUALITY MANUFACTURING TO AUGMENT MARKET GROWTH
7.3 PILOT-SCALE EQUIPMENT
7.3.1 INCREASED PHARMACEUTICAL R&D INVESTMENTS AND FOCUS ON EFFECTIVE QUALITY CONTROL IN LARGER OPERATIONS TO DRIVE MARKET
7.4 LABORATORY-SCALE EQUIPMENT
7.4.1 COST-EFFECTIVENESS, EASY OPERATION, AND LOW MAINTENANCE NEEDS TO FUEL MARKET GROWTH
8 PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY END USER
8.1 INTRODUCTION
8.2 PHARMACEUTICAL AND BIOTECH COMPANIES
8.2.1 INCREASED INVESTMENTS FOR BETTER PRODUCTION EFFICIENCY IN PHARMACEUTICAL INDUSTRY TO DRIVE MARKET
8.3 CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS
8.3.1 INCREASED OUTSOURCING OF RESEARCH AND MANUFACTURING PROCESSES BY PHARMA COMPANIES TO PROPEL MARKET GROWTH
8.4 RESEARCH ACADEMIES AND UNIVERSITIES
8.4.1 RISING DEMAND FOR ADVANCED LABORATORY AND RESEARCH FACILITIES IN ACADEMIC SETTINGS TO DRIVE MARKET
9 PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY REGION
9.1 INTRODUCTION
9.2 NORTH AMERICA
9.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
9.2.2 US
9.2.2.1 US to dominate North American pharmaceutical drying equipment market during forecast period
9.2.3 CANADA
9.2.3.1 Robust pharmaceutical sector and advancements in drug development to aid market growth
9.3 EUROPE
9.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
9.3.2 GERMANY
9.3.2.1 Increased R&D investments by key players and technological advancements to support market growth
9.3.3 FRANCE
9.3.3.1 Rising investments in bioproduction capacities to spur market growth
9.3.4 ITALY
9.3.4.1 Growing demand for biologics and biopharmaceuticals to boost market growth
9.3.5 UK
9.3.5.1 Increased government investments in pharmaceuticals and clinical trials to propel market growth
9.3.6 SPAIN
9.3.6.1 Increasing collaborations between drying equipment manufacturing companies to aid market growth
9.3.7 REST OF EUROPE
9.4 ASIA PACIFIC
9.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
9.4.2 CHINA
9.4.2.1 Technological advancements and strategic expansions by key international players to augment market growth
9.4.3 JAPAN
9.4.3.1 High investments in manufacturing capabilities and increased geriatric population to aid market growth
9.4.4 INDIA
9.4.4.1 Increasing investments in manufacturing facilities to propel market growth
9.4.5 AUSTRALIA
9.4.5.1 Rising demand for pharmaceuticals and increasing advancements in drug formulations to drive market
9.4.6 SOUTH KOREA
9.4.6.1 Increased popularity of CDMOs for pharmaceutical production to fuel market growth
9.4.7 REST OF ASIA PACIFIC
9.5 LATIN AMERICA
9.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
9.5.2 BRAZIL
9.5.2.1 Advanced biologics sector and increased demand for biosimilars to drive market
9.5.3 MEXICO
9.5.3.1 Burgeoning pharmaceutical industry and favorable trade agreements to propel market growth
9.5.4 REST OF LATIN AMERICA
9.6 MIDDLE EAST & AFRICA
9.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
9.6.2 GCC COUNTRIES
9.6.2.1 Expansion of pharmaceutical manufacturing companies to drive market
9.6.3 REST OF MIDDLE EAST & AFRICA
10 COMPETITIVE LANDSCAPE
10.1 INTRODUCTION
10.2 KEY PLAYER STRATEGY/RIGHT TO WIN
10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN PHARMACEUTICAL DRYING EQUIPMENT MARKET
10.3 REVENUE ANALYSIS, 2021–2023
10.4 MARKET SHARE ANALYSIS, 2023
10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
10.5.1 STARS
10.5.2 EMERGING LEADERS
10.5.3 PERVASIVE PLAYERS
10.5.4 PARTICIPANTS
10.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
10.5.5.1 Company footprint
10.5.5.2 Type footprint
10.5.5.3 Scale of operation footprint
10.5.5.4 End-user footprint
10.5.5.5 Region footprint
10.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
10.6.1 PROGRESSIVE COMPANIES
10.6.2 RESPONSIVE COMPANIES
10.6.3 DYNAMIC COMPANIES
10.6.4 STARTING BLOCKS
10.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
10.7 COMPANY VALUATION AND FINANCIAL METRICS
10.7.1 FINANCIAL METRICS
10.7.2 COMPANY VALUATION
10.8 BRAND/PRODUCT COMPARISON
10.9 COMPETITIVE SCENARIO
10.9.1 PRODUCT LAUNCHES
10.9.2 DEALS
10.9.3 EXPANSIONS
11 COMPANY PROFILES
11.1 KEY PLAYERS
11.1.1 GEA GROUP AKTIENGESELLSCHAFT
11.1.1.1 Business overview
11.1.1.2 Products offered
11.1.1.3 Recent developments
11.1.1.3.1 Deals
11.1.1.4 MnM view
11.1.1.4.1 Right to win
11.1.1.4.2 Strategic choices
11.1.1.4.3 Weaknesses and competitive threats
11.1.2 IMA INDUSTRIA MACCHINE AUTOMATICHE SPA
11.1.2.1 Business overview
11.1.2.2 Products offered
11.1.2.3 MnM view
11.1.2.3.1 Right to win
11.1.2.3.2 Strategic choices
11.1.2.3.3 Weaknesses and competitive threats
11.1.3 ATS CORPORATION
11.1.3.1 Business overview
11.1.3.2 Products offered
11.1.3.3 Recent developments
11.1.3.3.1 Product launches
11.1.3.3.2 Deals
11.1.3.3.3 Expansions
11.1.3.4 MnM view
11.1.3.4.1 Right to win
11.1.3.4.2 Strategic choices
11.1.3.4.3 Weaknesses and competitive threats
11.1.4 HOSOKAWA MICRON GROUP
11.1.4.1 Business overview
11.1.4.2 Products offered
11.1.4.3 MnM view
11.1.4.3.1 Right to win
11.1.4.3.2 Strategic choices
11.1.4.3.3 Weaknesses and competitive threats
11.1.5 FREUND CORP.
11.1.5.1 Business overview
11.1.5.2 Products offered
11.1.6 SYNTEGON TECHNOLOGY GMBH
11.1.6.1 Business overview
11.1.6.2 Products offered
11.1.6.3 Recent developments
11.1.6.3.1 Deals
11.1.7 BЬCHI LABORTECHNIK AG
11.1.7.1 Business overview
11.1.7.2 Products offered
11.1.7.3 Recent developments
11.1.7.3.1 Product launches
11.1.8 OPTIMA
11.1.8.1 Business overview
11.1.8.2 Products offered
11.1.9 MECHATECH SYSTEMS LTD.
11.1.9.1 Business overview
11.1.9.2 Products offered
11.1.10 BEW ENGINEERING
11.1.10.1 Business overview
11.1.10.2 Products offered
11.2 OTHER PLAYERS
11.2.1 ZIRBUS TECHNOLOGY GMBH
11.2.2 SPX FLOW, INC.
11.2.3 EUROPEAN SPRAYDRY TECHNOLOGIES
11.2.4 YAMATO SCIENTIFIC CO., LTD.
11.2.5 SAKA
11.2.6 ILSHIN BIOBASE
11.2.7 OKAWARA MFG. CO., LTD.
11.2.8 CHANGZHOU CHANGJIANG DRYING EQUIPMENT CO., LTD.
11.2.9 BACHILLER
11.2.10 MILLROCK TECHNOLOGY, INC.
11.2.11 MARTIN CHRIST GEFRIERTROCKNUNGSANLAGEN GMBH
11.2.12 LABCONCO
11.2.13 O’HARA TECHNOLOGIES
11.2.14 COOLVACUUM TECHNOLOGIES, SL
11.2.15 SHACHI ENGINEERING PVT. LTD.
12 APPENDIX
12.1 DISCUSSION GUIDE
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.3 CUSTOMIZATION OPTIONS
12.4 RELATED REPORTS
12.5 AUTHOR DETAILS
TABLE 1 PHARMACEUTICAL DRYING EQUIPMENT MARKET: INCLUSIONS & EXCLUSIONS
TABLE 2 CURRENCY CONVERSION RATES
TABLE 3 PHARMACEUTICAL DRYING EQUIPMENT MARKET: STUDY ASSUMPTIONS
TABLE 4 PHARMACEUTICAL DRYING EQUIPMENT MARKET: RISK ASSESSMENT
TABLE 5 PHARMACEUTICAL DRYING EQUIPMENT MARKET: PORTER’S FIVE FORCES
TABLE 6 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS FOR PHARMACEUTICAL DRYING EQUIPMENT
TABLE 7 KEY BUYING CRITERIA FOR PHARMACEUTICAL DRYING EQUIPMENT
TABLE 8 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS
TABLE 9 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS
TABLE 10 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS
TABLE 11 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS
TABLE 12 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT
AGENCIES, AND OTHER ORGANIZATIONS
TABLE 13 LIST OF PATENTS IN PHARMACEUTICAL DRYING EQUIPMENT MARKET, 2014?2024
TABLE 14 IMPORT DATA FOR HS CODE 8419, BY COUNTRY, 2018–2023 (USD MILLION)
TABLE 15 EXPORT DATA FOR HS CODE 8419, BY COUNTRY, 2018–2023 (USD MILLION)
TABLE 16 INDICATIVE SELLING PRICING OF DRYERS, 2021–2023
TABLE 17 INDICATIVE SELLING PRICE OF DRYERS, BY REGION, 2022–2024
TABLE 18 PHARMACEUTICAL DRYING EQUIPMENT MARKET: KEY CONFERENCES AND EVENTS, JANUARY 2024–DECEMBER 2025
TABLE 19 PHARMACEUTICAL DRYING EQUIPMENT MARKET: UNMET NEEDS
TABLE 20 PHARMACEUTICAL DRYING EQUIPMENT MARKET: END-USER EXPECTATIONS
TABLE 21 PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 22 SPRAY DRYERS OFFERED BY KEY PLAYERS
TABLE 23 PHARMACEUTICAL DRYING EQUIPMENT MARKET FOR SPRAY DRYERS,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 24 FREEZE DRYERS OFFERED BY KEY PLAYERS
TABLE 25 PHARMACEUTICAL DRYING EQUIPMENT MARKET FOR FREEZE DRYERS,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 26 FLUIDIZED BED DRYERS OFFERED BY KEY PLAYERS
TABLE 27 PHARMACEUTICAL DRYING EQUIPMENT MARKET FOR FLUIDIZED BED DRYERS,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 28 VACUUM DRYERS OFFERED BY KEY PLAYERS
TABLE 29 PHARMACEUTICAL DRYING EQUIPMENT MARKET FOR VACUUM DRYERS,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 30 PHARMACEUTICAL DRYING EQUIPMENT MARKET FOR OTHER DRYERS,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 31 OTHER DRYERS OFFERED BY KEY PLAYERS
TABLE 32 PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION)
TABLE 33 PHARMACEUTICAL DRYING EQUIPMENT MARKET FOR INDUSTRIAL-SCALE EQUIPMENT, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 34 PHARMACEUTICAL DRYING EQUIPMENT MARKET FOR PILOT-SCALE EQUIPMENT, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 35 PHARMACEUTICAL DRYING EQUIPMENT MARKET FOR LABORATORY-SCALE EQUIPMENT, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 36 PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY END USER,
2022–2029 (USD MILLION)
TABLE 37 PHARMACEUTICAL DRYING EQUIPMENT MARKET FOR PHARMACEUTICAL AND BIOTECH COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 38 PHARMACEUTICAL DRYING EQUIPMENT MARKET FOR CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 39 PHARMACEUTICAL DRYING EQUIPMENT MARKET FOR RESEARCH ACADEMIES AND UNIVERSITIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 40 PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY REGION,
2022–2029 (USD MILLION)
TABLE 41 NORTH AMERICA: PHARMACEUTICAL DRYING EQUIPMENT MARKET,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 42 NORTH AMERICA: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 43 NORTH AMERICA: PHARMACEUTICAL DRYING EQUIPMENT MARKET,
BY SCALE OF OPERATION, 2022–2029 (USD MILLION)
TABLE 44 NORTH AMERICA: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 45 US: KEY MACROINDICATORS
TABLE 46 US: PHARMACEUTICAL INDUSTRY LANDSCAPE
TABLE 47 US: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 48 US: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY SCALE
OF OPERATION, 2022–2029 (USD MILLION)
TABLE 49 US: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY END USER,
2022–2029 (USD MILLION)
TABLE 50 CANADA: KEY MACROINDICATORS
TABLE 51 CANADA: PHARMACEUTICAL INDUSTRY LANDSCAPE
TABLE 52 TOP FIVE EXPORTERS OF PHARMACEUTICAL PRODUCTS TO CANADA
TABLE 53 CANADA: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 54 CANADA: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION)
TABLE 55 CANADA: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY END USER,
2022–2029 (USD MILLION)
TABLE 56 EUROPE: PHARMACEUTICAL INDUSTRY LANDSCAPE
TABLE 57 EUROPE: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 58 EUROPE: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 59 EUROPE: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION)
TABLE 60 EUROPE: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY END USER,
2022–2029 (USD MILLION)
TABLE 61 GERMANY: KEY MACROINDICATORS
TABLE 62 GERMANY: PHARMACEUTICAL INDUSTRY LANDSCAPE
TABLE 63 GERMANY: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 64 GERMANY: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION)
TABLE 65 GERMANY: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 66 FRANCE: KEY MACROINDICATORS
TABLE 67 FRANCE: PHARMACEUTICAL INDUSTRY LANDSCAPE
TABLE 68 FRANCE: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 69 FRANCE: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION)
TABLE 70 FRANCE: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY END USER,
2022–2029 (USD MILLION)
TABLE 71 ITALY: KEY MACROINDICATORS
TABLE 72 ITALY: PHARMACEUTICAL INDUSTRY LANDSCAPE
TABLE 73 ITALY: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 74 ITALY: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION)
TABLE 75 ITALY: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY END USER,
2022–2029 (USD MILLION)
TABLE 76 UK: KEY MACROINDICATORS
TABLE 77 UK: PHARMACEUTICAL INDUSTRY LANDSCAPE
TABLE 78 UK: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 79 UK: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION)
TABLE 80 UK: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY END USER,
2022–2029 (USD MILLION)
TABLE 81 SPAIN: KEY MACROINDICATORS
TABLE 82 SPAIN: PHARMACEUTICAL INDUSTRY LANDSCAPE
TABLE 83 SPAIN: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 84 SPAIN: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION)
TABLE 85 SPAIN: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY END USER,
2022–2029 (USD MILLION)
TABLE 86 SWITZERLAND: PHARMACEUTICAL INDUSTRY LANDSCAPE
TABLE 87 POLAND: PHARMACEUTICAL INDUSTRY LANDSCAPE
TABLE 88 BELGIUM: PHARMACEUTICAL PRODUCTION VALUE (USD MILLION)
TABLE 89 AUSTRIA: PHARMACEUTICAL PRODUCTION VALUE (USD MILLION)
TABLE 90 IRELAND: PHARMACEUTICAL INDUSTRY LANDSCAPE
TABLE 91 REST OF EUROPE: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 92 REST OF EUROPE: PHARMACEUTICAL DRYING EQUIPMENT MARKET,
BY SCALE OF OPERATION, 2022–2029 (USD MILLION)
TABLE 93 REST OF EUROPE: PHARMACEUTICAL DRYING EQUIPMENT MARKET,
BY END USER, 2022–2029 (USD MILLION)
TABLE 94 ASIA PACIFIC: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 95 ASIA PACIFIC: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 96 ASIA PACIFIC: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION)
TABLE 97 ASIA PACIFIC: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 98 CHINA: KEY MACROINDICATORS
TABLE 99 CHINA: PHARMACEUTICAL INDUSTRY LANDSCAPE
TABLE 100 CHINA: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 101 CHINA: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION)
TABLE 102 CHINA: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY END USER,
2022–2029 (USD MILLION)
TABLE 103 JAPAN: KEY MACROINDICATORS
TABLE 104 JAPAN: PHARMACEUTICAL INDUSTRY LANDSCAPE
TABLE 105 JAPAN: PHARMACEUTICAL PRODUCTION, BY DOSAGE FORM
TABLE 106 JAPAN: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 107 JAPAN: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION)
TABLE 108 JAPAN: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY END USER,
2022–2029 (USD MILLION)
TABLE 109 INDIA: KEY MACROINDICATORS
TABLE 110 INDIA: PHARMACEUTICAL INDUSTRY LANDSCAPE
TABLE 111 INDIA: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 112 INDIA: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION)
TABLE 113 INDIA: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY END USER,
2022–2029 (USD MILLION)
TABLE 114 AUSTRALIA: KEY MACROINDICATORS
TABLE 115 AUSTRALIA: PHARMACEUTICAL INDUSTRY LANDSCAPE
TABLE 116 AUSTRALIA: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 117 AUSTRALIA: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION)
TABLE 118 AUSTRALIA: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 119 SOUTH KOREA: KEY MACROINDICATORS
TABLE 120 SOUTH KOREA: PHARMACEUTICAL MANUFACTURERS SIZE
TABLE 121 SOUTH KOREA: PHARMACEUTICAL PRODUCTION VALUE (USD BILLION)
TABLE 122 SOUTH KOREA: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 123 SOUTH KOREA: PHARMACEUTICAL DRYING EQUIPMENT MARKET,
BY SCALE OF OPERATION, 2022–2029 (USD MILLION)
TABLE 124 SOUTH KOREA: PHARMACEUTICAL DRYING EQUIPMENT MARKET,
BY END USER, 2022–2029 (USD MILLION)
TABLE 125 SINGAPORE: PHARMACEUTICAL INDUSTRY LANDSCAPE
TABLE 126 SINGAPORE: PHARMACEUTICAL AND BIOLOGICAL PRODUCTION INDEX
(2019–2023)
TABLE 127 MALAYSIA: PHARMACEUTICAL INDUSTRY LANDSCAPE
TABLE 128 REST OF ASIA PACIFIC: PHARMACEUTICAL DRYING EQUIPMENT MARKET,
BY TYPE, 2022–2029 (USD MILLION)
TABLE 129 REST OF ASIA PACIFIC: PHARMACEUTICAL DRYING EQUIPMENT MARKET,
BY SCALE OF OPERATION, 2022–2029 (USD MILLION)
TABLE 130 REST OF ASIA PACIFIC: PHARMACEUTICAL DRYING EQUIPMENT MARKET,
BY END USER, 2022–2029 (USD MILLION)
TABLE 131 LATIN AMERICA: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 132 LATIN AMERICA: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 133 LATIN AMERICA: PHARMACEUTICAL DRYING EQUIPMENT MARKET,
BY SCALE OF OPERATION, 2022–2029 (USD MILLION)
TABLE 134 LATIN AMERICA: PHARMACEUTICAL DRYING EQUIPMENT MARKET,
BY END USER, 2022–2029 (USD MILLION)
TABLE 135 BRAZIL: KEY MACROINDICATORS
TABLE 136 BRAZIL: PHARMACEUTICAL INDUSTRY LANDSCAPE
TABLE 137 BRAZIL: IMPORT VALUE OF PHARMACEUTICAL PRODUCTS (2020–2023)
TABLE 138 BRAZIL: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 139 BRAZIL: PHARMACEUTICAL DRYING EQUIPMENT MARKET,
BY SCALE OF OPERATION, 2022–2029 (USD MILLION)
TABLE 140 BRAZIL: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY END USER,
2022–2029 (USD MILLION)
TABLE 141 MEXICO: KEY MACROINDICATORS
TABLE 142 MEXICO: PHARMACEUTICAL INDUSTRY LANDSCAPE
TABLE 143 MEXICO: PHARMACEUTICAL PRODUCTS IMPORT-EXPORT VALUE (2020–2023)
TABLE 144 MEXICO: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 145 MEXICO: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION)
TABLE 146 MEXICO: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY END USER,
2022–2029 (USD MILLION)
TABLE 147 ARGENTINA: PHARMACEUTICAL INDUSTRY LANDSCAPE
TABLE 148 ARGENTINA: PHARMACEUTICAL PRODUCTS IMPORT-EXPORT VALUE
TABLE 149 REST OF LATIN AMERICA: PHARMACEUTICAL DRYING EQUIPMENT MARKET,
BY TYPE, 2022–2029 (USD MILLION)
TABLE 150 REST OF LATIN AMERICA: PHARMACEUTICAL DRYING EQUIPMENT MARKET,
BY SCALE OF OPERATION, 2022–2029 (USD MILLION)
TABLE 151 REST OF LATIN AMERICA: PHARMACEUTICAL DRYING EQUIPMENT MARKET,
BY END USER, 2022–2029 (USD MILLION)
TABLE 152 MIDDLE EAST & AFRICA: PHARMACEUTICAL DRYING EQUIPMENT MARKET,
BY REGION, 2022–2029 (USD MILLION)
TABLE 153 MIDDLE EAST & AFRICA: PHARMACEUTICAL DRYING EQUIPMENT MARKET,
BY TYPE, 2022–2029 (USD MILLION)
TABLE 154 MIDDLE EAST & AFRICA: PHARMACEUTICAL DRYING EQUIPMENT MARKET,
BY SCALE OF OPERATION, 2022–2029 (USD MILLION)
TABLE 155 MIDDLE EAST & AFRICA: PHARMACEUTICAL DRYING EQUIPMENT MARKET,
BY END USER, 2022–2029 (USD MILLION)
TABLE 156 UAE: GROWTH RATE OF PHARMACEUTICAL MANUFACTURING PLANT,
2010 VS. 2021
TABLE 157 SAUDI ARABIA: PHARMACEUTICAL INDUSTRY LANDSCAPE
TABLE 158 GCC COUNTRIES: PHARMACEUTICAL DRYING EQUIPMENT MARKET,
BY TYPE, 2022–2029 (USD MILLION)
TABLE 159 GCC COUNTRIES: PHARMACEUTICAL DRYING EQUIPMENT MARKET,
BY SCALE OF OPERATION, 2022–2029 (USD MILLION)
TABLE 160 GCC COUNTRIES: PHARMACEUTICAL DRYING EQUIPMENT MARKET,
BY END USER, 2022–2029 (USD MILLION)
TABLE 161 REST OF MIDDLE EAST & AFRICA: PHARMACEUTICAL INDUSTRY LANDSCAPE
TABLE 162 SOUTH AFRICA: PHARMACEUTICAL PRODUCTS IMPORT-EXPORT VALUE
TABLE 163 EGYPT: PHARMACEUTICAL PRODUCTS IMPORT-EXPORT VALUE
TABLE 164 GHANA: PHARMACEUTICAL PRODUCTS IMPORT-EXPORT VALUE
TABLE 165 KENYA: PHARMACEUTICAL PRODUCTS IMPORT-EXPORT VALUE
TABLE 166 ETHIOPIA: PHARMACEUTICAL PRODUCTS IMPORT-EXPORT VALUE
TABLE 167 REST OF MIDDLE EAST & AFRICA: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 168 REST OF MIDDLE EAST & AFRICA: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION)
TABLE 169 REST OF MIDDLE EAST & AFRICA: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 170 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN PHARMACEUTICAL DRYING EQUIPMENT MARKET
TABLE 171 PHARMACEUTICAL DRYING EQUIPMENT MARKET: DEGREE OF COMPETITION
TABLE 172 PHARMACEUTICAL DRYING EQUIPMENT MARKET: TYPE FOOTPRINT
TABLE 173 PHARMACEUTICAL DRYING EQUIPMENT MARKET:
SCALE OF OPERATION FOOTPRINT
TABLE 174 PHARMACEUTICAL DRYING EQUIPMENT MARKET: END-USER FOOTPRINT
TABLE 175 PHARMACEUTICAL DRYING EQUIPMENT MARKET: REGION FOOTPRINT
TABLE 176 PHARMACEUTICAL DRYING EQUIPMENT MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYER
TABLE 177 PHARMACEUTICAL DRYING EQUIPMENT MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS
TABLE 178 PHARMACEUTICAL DRYING EQUIPMENT MARKET: PRODUCT LAUNCHES, JANUARY 2021–AUGUST 2024
TABLE 179 PHARMACEUTICAL DRYING EQUIPMENT MARKET: DEALS,
JANUARY 2021–AUGUST 2024
TABLE 180 PHARMACEUTICAL DRYING EQUIPMENT MARKET: EXPANSIONS,
JANUARY 2021–AUGUST 2024
TABLE 181 GEA GROUP AKTIENGESELLSCHAFT: COMPANY OVERVIEW
TABLE 182 GEA GROUP AKTIENGESELLSCHAFT: PRODUCTS OFFERED
TABLE 183 GEA GROUP AKTIENGESELLSCHAFT: DEALS, JANUARY 2021–AUGUST 2024
TABLE 184 IMA INDUSTRIA MACCHINE AUTOMATICHE SPA: COMPANY OVERVIEW
TABLE 185 IMA INDUSTRIA MACCHINE AUTOMATICHE SPA: PRODUCTS OFFERED
TABLE 186 ATS CORPORATION: COMPANY OVERVIEW
TABLE 187 ATS CORPORATION: PRODUCTS OFFERED
TABLE 188 ATS CORPORATION PRODUCT LAUNCHES, JANUARY 2021–AUGUST 2024
TABLE 189 ATS CORPORATION: DEALS, JANUARY 2021–AUGUST 2024
TABLE 190 ATS CORPORATION: EXPANSIONS, JANUARY 2021–AUGUST 2024
TABLE 191 HOSOKAWA MICRON GROUP: COMPANY OVERVIEW
TABLE 192 HOSOKAWA MICRON GROUP: PRODUCTS OFFERED
TABLE 193 FREUND CORP.: COMPANY OVERVIEW
TABLE 194 FREUND CORP.: PRODUCTS OFFERED
TABLE 195 SYNTEGON TECHNOLOGY GMBH: COMPANY OVERVIEW
TABLE 196 SYNTEGON TECHNOLOGY GMBH: PRODUCTS OFFERED
TABLE 197 SYNTEGON TECHNOLOGY GMBH: DEALS, JANUARY 2021–AUGUST 2024
TABLE 198 BЬCHI LABORTECHNIK AG.: COMPANY OVERVIEW
TABLE 199 BЬCHI LABORTECHNIK AG: PRODUCTS OFFERED
TABLE 200 BЬCHI LABORTECHNIK AG: PRODUCT LAUNCHES, JANUARY 2021–AUGUST 2024
TABLE 201 OPTIMA: COMPANY OVERVIEW
TABLE 202 OPTIMA: PRODUCTS OFFERED
TABLE 203 MECHATECH SYSTEMS LTD.: COMPANY OVERVIEW
TABLE 204 MECHATECH SYSTEMS LTD.: PRODUCTS OFFERED
TABLE 205 BEW ENGINEERING: COMPANY OVERVIEW
TABLE 206 BEW ENGINEERING: PRODUCTS OFFERED
TABLE 207 ZIRBUS TECHNOLOGY GMBH: COMPANY OVERVIEW
TABLE 208 SPX FLOW, INC.: COMPANY OVERVIEW
TABLE 209 EUROPEAN SPRAYDRY TECHNOLOGIES: COMPANY OVERVIEW
TABLE 210 YAMATO SCIENTIFIC CO., LTD.: COMPANY OVERVIEW
TABLE 211 SAKA: COMPANY OVERVIEW
TABLE 212 ILSHIN BIOBASE: COMPANY OVERVIEW
TABLE 213 OKAWARA MFG. CO., LTD.: COMPANY OVERVIEW
TABLE 214 CHANGZHOU CHANGJIANG DRYING EQUIPMENT CO., LTD.: COMPANY OVERVIEW
TABLE 215 BACHILLER: COMPANY OVERVIEW
TABLE 216 MILLROCK TECHNOLOGY, INC.: COMPANY OVERVIEW
TABLE 217 MARTIN CHRIST GEFRIERTROCKNUNGSANLAGEN GMBH: COMPANY OVERVIEW
TABLE 218 LABCONCO: COMPANY OVERVIEW
TABLE 219 O’HARA TECHNOLOGIES: COMPANY OVERVIEW
TABLE 220 COOLVACUUM TECHNOLOGIES, SL: COMPANY OVERVIEW
TABLE 221 SHACHI ENGINEERING PVT. LTD.: COMPANY OVERVIEW
